Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children who are older than 2 years and younger than 16 years old, with no genetic conditions
- Children who have been newly diagnosed with mild-to-moderate ulcerative colitis (a type of bowel inflammation), measured using a standard scoring tool called the PUCAI, as part of the first-line treatment group
- Children with mild-to-moderate ulcerative colitis whose condition has not responded to standard treatments such as hormones, immune-suppressing medicines, or biologic medicines, as part of the refractory (hard-to-treat) group
- Children and families who agree to have regular colonoscopy procedures (camera examinations of the bowel) during the trial
Who may not be able to join:
- Children who have received a specific type of nutritional feeding called PEN (at 80% of nutrition) for less than 8 weeks
- Children in the first-line treatment group who have already been treated with corticosteroids, methotrexate, thiopurines, or anti-TNF medicines as their first treatment
- Children who have a known medical reason why all methods of delivering FMT (a treatment using donated stool) cannot be used — this includes nasal tube feeding, camera procedures of the upper digestive tract, bowel camera procedures, enemas, and capsule methods
- Children or families who are unwilling to provide consent to participate in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhihua Huang, Tongji Hospital
Phone: +8685726753
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
clinical response; clinical remission; safety of FMT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.